


Healthcare News Roundup: Personnel
HSMN NewsFeed - 6 Oct 2017
Intezyne Closes Oversubscribed $10M Series A Financing to Drive Rapid Oncology Portfolio Development
Intezyne Closes Oversubscribed $10M Series A Financing to Drive Rapid Oncology Portfolio Development
HSMN NewsFeed - 6 Oct 2017
Norbert Oppitz Joins Sobi(TM) as New Senior Vice President, Specialty Care
Norbert Oppitz Joins Sobi(TM) as New Senior Vice President, Specialty Care
HSMN NewsFeed - 5 Oct 2017
IFM Therapeutics LLC Appoints William R. Roush as Executive Vice President of Chemistry
IFM Therapeutics LLC Appoints William R. Roush as Executive Vice President of Chemistry
HSMN NewsFeed - 4 Oct 2017
Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
Boston Scientific Appoints Desiree Ralls-Morrison General Counsel and Corporate Secretary
HSMN NewsFeed - 3 Oct 2017
Oncorus(R), Inc., Names Christophe Quéva, Ph.D., as Chief Scientific Officer
Oncorus(R), Inc., Names Christophe Quéva, Ph.D., as Chief Scientific Officer
HSMN NewsFeed - 3 Oct 2017
Dr. Gloria Matthews Joins MiMedx As Its Senior Vice President Of Research And Development
Dr. Gloria Matthews Joins MiMedx As Its Senior Vice President Of Research And Development
HSMN NewsFeed - 3 Oct 2017
BioMarin Appoints Robert J. Hombach, Former Baxalta CFO and COO, to Board of Directors
BioMarin Appoints Robert J. Hombach, Former Baxalta CFO and COO, to Board of Directors
HSMN NewsFeed - 29 Sep 2017
Dermavant Sciences Appoints Vince Ippolito as President and Chief Operating Officer
Dermavant Sciences Appoints Vince Ippolito as President and Chief Operating Officer
HSMN NewsFeed - 29 Sep 2017
Lilly Announces Senior Leadership Appointments for Finance, Research & Development and Manufacturing
Lilly Announces Senior Leadership Appointments for Finance, Research & Development and Manufacturing
HSMN NewsFeed - 26 Sep 2017
CTI BioPharma Appoints Laurent Fischer as New Chairman of the Board and Announces Management Promotions
CTI BioPharma Appoints Laurent Fischer as New Chairman of the Board and Announces Management Promotions
HSMN NewsFeed - 22 Sep 2017
Bayer Appoints Dr. Sharon James Head of Global Innovation & Development for Consumer Health
Bayer Appoints Dr. Sharon James Head of Global Innovation & Development for Consumer Health
HSMN NewsFeed - 20 Sep 2017
DURECT Appoints Dr. Myriam Theeuwes as Senior Vice President, Clinical Development
DURECT Appoints Dr. Myriam Theeuwes as Senior Vice President, Clinical Development
HSMN NewsFeed - 20 Sep 2017
Arvinas Appoints Dr. John Houston as President and Chief Executive Officer
Arvinas Appoints Dr. John Houston as President and Chief Executive Officer
HSMN NewsFeed - 19 Sep 2017
Organogenesis Names New Chief Commercial Officer and Chief Operating Officer
Organogenesis Names New Chief Commercial Officer and Chief Operating Officer
HSMN NewsFeed - 18 Sep 2017
Kaleido Biosciences Announces Appointment of Mike Bonney as CEO and Completion of Additional Fundraising
Kaleido Biosciences Announces Appointment of Mike Bonney as CEO and Completion of Additional Fundraising
HSMN NewsFeed - 18 Sep 2017
Abide Therapeutics Appoints Dr. Sapna Srivastava As Chief Financial and Strategy Officer
Abide Therapeutics Appoints Dr. Sapna Srivastava As Chief Financial and Strategy Officer
HSMN NewsFeed - 13 Sep 2017
Amarin Appoints Mark W. Salyer to New Position of Chief Commercial Officer
Amarin Appoints Mark W. Salyer to New Position of Chief Commercial Officer
HSMN NewsFeed - 11 Sep 2017
Kindred Biosciences Announces Plans for Promotion of Dr. Zhan and Retirement of Dr. Sundlof
Kindred Biosciences Announces Plans for Promotion of Dr. Zhan and Retirement of Dr. Sundlof
HSMN NewsFeed - 8 Sep 2017
Replimune Raises $55 Million to Advance its Oncolytic Immunotherapy Programs
Replimune Raises $55 Million to Advance its Oncolytic Immunotherapy Programs
HSMN NewsFeed - 7 Sep 2017
Vividion Therapeutics Appoints Diego Miralles, M.D., Chief Executive Officer
Vividion Therapeutics Appoints Diego Miralles, M.D., Chief Executive Officer
HSMN NewsFeed - 6 Sep 2017
Oxeia Biopharmaceuticals, Inc. Announces Appointment Of Dr. Michael Wyand As Chief Executive Officer
Oxeia Biopharmaceuticals, Inc. Announces Appointment Of Dr. Michael Wyand As Chief Executive Officer
HSMN NewsFeed - 6 Sep 2017
SCA Pharmaceuticals Announces the Retirement of Dr. Gene Graves, Founder and Chief Executive Officer
SCA Pharmaceuticals Announces the Retirement of Dr. Gene Graves, Founder and Chief Executive Officer
HSMN NewsFeed - 30 Aug 2017
PhRMA Announces Dr. Richard Moscicki as New Chief Medical Officer and Executive Vice President
PhRMA Announces Dr. Richard Moscicki as New Chief Medical Officer and Executive Vice President
HSMN NewsFeed - 17 Aug 2017
BlueRock Therapeutics Expands Toronto Presence with R&D and Manufacturing Hub, Appoints Key R&D Leadership
BlueRock Therapeutics Expands Toronto Presence with R&D and Manufacturing Hub, Appoints Key R&D Leadership
